The results showed that MDRN could significantly improve oxidative stress and inflammatory response in myocardial ischemia-hypoxia model cells by activating the PI3K/AKT/mTOR signaling pathway, enhancing cell viability and mitochondrial membrane potential. The gene discussed is AKT1; the disease is myocardial ischemia.